This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
Newsramp
newsramp.com
did:plc:xlsujlrwr5xpfxgaf4pixhri
Landmark proton therapy trial shows 90.9% five-year survival for oropharyngeal cancer vs. 81% with traditional radiation. Precision targeting reduces harmful exposure to healthy tissue, reshaping cancer treatment infrastructure. #ProtonTherapy #Oncology
2026-05-15T06:24:34.373Z